News & Resources

The Future of Oncology Conferences and Expert Meetings After COVID-19

While the increase in COVID-19 infections—largely due to the spread of the delta variant—is causing governments and health organizations worldwide to sound the alarm once again on high-risk social practices, it’s time to revisit using virtual platforms for oncology and hematology conferences and data-gathering meetings.

Just like the rest of the world, healthcare providers are experiencing so-called “Zoom fatigue.” At the same time, a poll of 900 Nature readers (including scientists, doctors, and researchers) revealed that 74% of respondents believe scientific meetings should continue to be virtual or have a virtual component even after the pandemic ends.

The challenge is how to keep virtual medical congresses engaging and, moreover, productive. In a previous post, we explored how the COVID-19 pandemic is changing key opinion leader engagement, and in another post, 5 tips for successful virtual meetings were outlined. This post will go beyond those topics and further explore the advantages and disadvantages of virtual meetings post-coronavirus and identify potential areas for improvement and innovation.

Embracing virtual formats
During the COVID-19 outbreak, forums for sharing important medical information saw an obligation to endure. Conventional, industry-wide meetings were needed more than ever in order to address changes in health care delivery and new protocols in the wake of a worldwide epidemic. Cancer care, for example, couldn’t just be put on hold, and new approaches had to be adopted to keep both healthcare workers and patients as safe as possible.

In response, conference organizers quickly adopted virtual strategies. As the world tries to get back to “normal,” the reality is that COVID-19 will have a permanent impact on the future operations of most industry-level events, including large medical meetings. Life science companies and healthcare organizations that sponsor these information-sharing events will need to embrace online formats going forward. Of course, medical communications experts associated with strategic groups like Aptitude Health are here to help.

Digital technologies afford better engagement strategies
In-depth planning helps make your meeting a success. During the spring and summer, many organizations rushed to move their operations online; this rapid change may not have allowed your organization much time to prepare. Creating a strategy saves time and money—careful planning allows your organization to focus on forging connections with recognized experts.

If you’re planning on reaching out to healthcare providers (HCPs), develop a game plan. First, target the right individuals. Identify HCPs who are tech savvy and open to your message. HCPs who are already comfortable with virtual tools make the best contacts; these experts are at ease arranging meetings and networking online.

Take time to consider whether your contacts are already familiar with your company. Virtual meetings work best when HCPs have a positive, open-minded attitude. If your contacts are reluctant to hear your message, it might be best to wait until you can meet in person.

Virtual meetings are often less expensive than in-person meetings, but they still require time, money, and employee investment. Make the most of these resources by identifying providers who are likely to be responsive.

Online information-sharing events have greater reach
Of course, virtual conferences and other online initiatives such as disease state academies provide a much broader, global reach than conventional live meetings. Accessibility is a huge advantage: some researchers noted that they’ve been able to attend more meetings than ever due to the convenient online format. These virtual events have also helped some professionals strike a better work/life balance, particularly those who teach or have small children.

By waiving travel, the total cost of attending a live meeting is far lower, enabling other career groups like students to take part in greater numbers. And online talks can also be saved for future viewing, better accommodating busy schedules. In fact, 600 surveyed physicians indicated an equal preference for watching a webinar live vs recorded.

Socialization loss – the biggest disadvantage of virtual events
In the survey analyzing the impact of COVID-19 on medical conferences and continuing education programs, 55% of the respondents dislike the unsociable aspect of virtual meetings. In the Nature survey, 69% of respondents said the biggest drawback to virtual conferences is poor networking opportunities. So, while conference attendees expressed appreciation for online formats, they miss interacting with friends and colleagues.

There is also a need to combat screen-time fatigue and time-zone conflicts. Instead of an all-consuming schedule of events, a few logistic changes can improve the overall virtual experience. Best practices for online meetings include hosting events on weekends rather than weekdays, keeping talks or webinars under 2 hours, and meeting in the evenings. Furthermore, physicians are more engaged by detailed topics rather than broad topics.

The future of virtual medical meetings
To replicate the collaborative spirit and social aspect of traditional face-to-face events, virtual conference coordinators need to introduce new platforms that support greater interaction among attendees and organizers and provide specific networking opportunities. Some workarounds to the socialization problem include formal mentorship programs that pair early career scientists or students with established scientists, and virtual “lobbies” that facilitate meet-and-greet opportunities between presentations.

Conference hosts should strive to create a unique online experience targeted at meeting attendees, which ultimately requires a nuanced understanding of their communication and content preferences. Aptitude Health, for example, can provide expert insights into the preferences of scientists working in the oncology and hematology sectors. Premium insights from a partner with specific expertise can help you build an engaging online experience.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.
Aptitude Health
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.